Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPGP20 is a pseudogene described as "small nuclear ribonucleoprotein polypeptide G pseudogene 20." Pseudogenes are genomic sequences similar to known genes but typically lack the ability to encode functional proteins due to mutations or incomplete transcription. Although some pseudogenes can regulate their parental genes or participate in non-coding RNA networks, there is no evidence for functional roles, therapeutic targeting, or disease associations specifically attributed to SNRPGP20.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 20 (SNRPGP20).